HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.
Saved in:
| Title: | HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study. |
|---|---|
| Authors: | Rabinowits G; 1Department of Hematology and Oncology, Miami Cancer Institute/Baptist Health South Florida, Miami, FL., Park SJ; 2Department of Medicine, Division of Hematology and Oncology, University of California San Diego, La Jolla, CA; NIK., Khushalani NI; 3Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL., Panella T; 4Division of Hematology and Oncology, University of Tennessee Medical Center, Knoxville, TN., Ellison DM; 5Charleston Oncology, Charleston, SC., Gentry RW; 6CARTI Cancer Center, Little Rock, AR., Venna SS; 7Inova Schar Cancer Institute Melanoma Center, Fairfax, VA., Strasswimmer J; 8Florida Atlantic University College of Medicine, Boca Raton, FL., Zuniga RM; 9New York Cancer and Blood Specialists, Babylon, NY., Chandra S; 10Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL., Ruiz ES; 11Department of Dermatology, Brigham and Women's Hospital, Boston, MA., Migden MR; 12Departments of Dermatology and Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX., Ibrahim SF; 13Rochester Dermatologic Surgery, PC, Victor, NY., Yan E; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Zhu C; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Pouliot JF; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Quek RGW; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY. |
| Source: | Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Mar 31; Vol. 24 (3.5). Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41991096 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rabinowits+G%22">Rabinowits G</searchLink>; 1Department of Hematology and Oncology, Miami Cancer Institute/Baptist Health South Florida, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Park+SJ%22">Park SJ</searchLink>; 2Department of Medicine, Division of Hematology and Oncology, University of California San Diego, La Jolla, CA; NIK.<br /><searchLink fieldCode="AU" term="%22Khushalani+NI%22">Khushalani NI</searchLink>; 3Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Panella+T%22">Panella T</searchLink>; 4Division of Hematology and Oncology, University of Tennessee Medical Center, Knoxville, TN.<br /><searchLink fieldCode="AU" term="%22Ellison+DM%22">Ellison DM</searchLink>; 5Charleston Oncology, Charleston, SC.<br /><searchLink fieldCode="AU" term="%22Gentry+RW%22">Gentry RW</searchLink>; 6CARTI Cancer Center, Little Rock, AR.<br /><searchLink fieldCode="AU" term="%22Venna+SS%22">Venna SS</searchLink>; 7Inova Schar Cancer Institute Melanoma Center, Fairfax, VA.<br /><searchLink fieldCode="AU" term="%22Strasswimmer+J%22">Strasswimmer J</searchLink>; 8Florida Atlantic University College of Medicine, Boca Raton, FL.<br /><searchLink fieldCode="AU" term="%22Zuniga+RM%22">Zuniga RM</searchLink>; 9New York Cancer and Blood Specialists, Babylon, NY.<br /><searchLink fieldCode="AU" term="%22Chandra+S%22">Chandra S</searchLink>; 10Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Ruiz+ES%22">Ruiz ES</searchLink>; 11Department of Dermatology, Brigham and Women's Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Migden+MR%22">Migden MR</searchLink>; 12Departments of Dermatology and Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Ibrahim+SF%22">Ibrahim SF</searchLink>; 13Rochester Dermatologic Surgery, PC, Victor, NY.<br /><searchLink fieldCode="AU" term="%22Yan+E%22">Yan E</searchLink>; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Zhu+C%22">Zhu C</searchLink>; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Pouliot+JF%22">Pouliot JF</searchLink>; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY.<br /><searchLink fieldCode="AU" term="%22Quek+RGW%22">Quek RGW</searchLink>; 14Regeneron Pharmaceuticals, Inc., Tarrytown, NY. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101162515%22">Journal of the National Comprehensive Cancer Network : JNCCN</searchLink> [J Natl Compr Canc Netw] 2026 Mar 31; Vol. 24 (3.5). <i>Date of Electronic Publication: </i>2026 Mar 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Harborside+Press%22">Harborside Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101162515 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1540-1413 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215401405%22">15401405 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Compr Canc Netw <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41991096 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.6004/jnccn.2025.7298 Languages: – Code: eng Text: English Titles: – TitleFull: HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rabinowits G – PersonEntity: Name: NameFull: Park SJ – PersonEntity: Name: NameFull: Khushalani NI – PersonEntity: Name: NameFull: Panella T – PersonEntity: Name: NameFull: Ellison DM – PersonEntity: Name: NameFull: Gentry RW – PersonEntity: Name: NameFull: Venna SS – PersonEntity: Name: NameFull: Strasswimmer J – PersonEntity: Name: NameFull: Zuniga RM – PersonEntity: Name: NameFull: Chandra S – PersonEntity: Name: NameFull: Ruiz ES – PersonEntity: Name: NameFull: Migden MR – PersonEntity: Name: NameFull: Ibrahim SF – PersonEntity: Name: NameFull: Yan E – PersonEntity: Name: NameFull: Zhu C – PersonEntity: Name: NameFull: Pouliot JF – PersonEntity: Name: NameFull: Quek RGW IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 03 Text: 2026 Mar 31 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1540-1413 Numbering: – Type: volume Value: 24 – Type: issue Value: 3.5 Titles: – TitleFull: Journal of the National Comprehensive Cancer Network : JNCCN Type: main |
| ResultId | 1 |
